DE602004028821D1 - Pyrrolidiniumderivative als liganden für den muscarinen m3-rezeptor - Google Patents

Pyrrolidiniumderivative als liganden für den muscarinen m3-rezeptor

Info

Publication number
DE602004028821D1
DE602004028821D1 DE602004028821T DE602004028821T DE602004028821D1 DE 602004028821 D1 DE602004028821 D1 DE 602004028821D1 DE 602004028821 T DE602004028821 T DE 602004028821T DE 602004028821 T DE602004028821 T DE 602004028821T DE 602004028821 D1 DE602004028821 D1 DE 602004028821D1
Authority
DE
Germany
Prior art keywords
muscarin
ligands
receptor
pyrrolidinium derivatives
pyrrolidinium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004028821T
Other languages
English (en)
Inventor
Stephen Paul Collingwood
Urs Baettig
Clive Mccarthy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33554160&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004028821(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0314697A external-priority patent/GB0314697D0/en
Priority claimed from GB0327526A external-priority patent/GB0327526D0/en
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE602004028821D1 publication Critical patent/DE602004028821D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602004028821T 2003-06-24 2004-06-23 Pyrrolidiniumderivative als liganden für den muscarinen m3-rezeptor Expired - Lifetime DE602004028821D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0314697A GB0314697D0 (en) 2003-06-24 2003-06-24 Organic compounds
GB0327526A GB0327526D0 (en) 2003-11-26 2003-11-26 Organic compounds
PCT/EP2004/006795 WO2005000815A2 (en) 2003-06-24 2004-06-23 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor

Publications (1)

Publication Number Publication Date
DE602004028821D1 true DE602004028821D1 (de) 2010-10-07

Family

ID=33554160

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004028821T Expired - Lifetime DE602004028821D1 (de) 2003-06-24 2004-06-23 Pyrrolidiniumderivative als liganden für den muscarinen m3-rezeptor

Country Status (15)

Country Link
US (1) US7947730B2 (de)
EP (1) EP1638940B1 (de)
JP (1) JP2008529965A (de)
AR (1) AR044851A1 (de)
AT (1) ATE478845T1 (de)
AU (1) AU2004251867B2 (de)
BR (1) BRPI0411738A (de)
CA (1) CA2526991C (de)
DE (1) DE602004028821D1 (de)
MX (1) MXPA05013823A (de)
PE (1) PE20050231A1 (de)
PL (1) PL1638940T3 (de)
PT (1) PT1638940E (de)
TW (1) TW200526573A (de)
WO (1) WO2005000815A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0410712D0 (en) 2004-05-13 2004-06-16 Novartis Ag Organic compounds
GB0428418D0 (en) * 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0428416D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
EP1957451B1 (de) 2005-11-10 2011-10-19 Nicholas S. Bodor Weiche anticholinerge zwitterionen
CA2627982C (en) 2005-11-10 2013-09-10 Nicholas S. Bodor Soft anticholinergic esters
JP2009519310A (ja) * 2005-12-16 2009-05-14 アージェンタ ディスカバリー リミテッド 環状アミン誘導体およびそれらの使用
JP2009534463A (ja) * 2006-04-24 2009-09-24 アストラゼネカ・アクチエボラーグ 例えば慢性気管支閉塞、喘息および過活動膀胱の処置に有用な、ムスカリンm3受容体アンタゴニスト活性を有する環状アミノアルコールの新規アルキルエステル
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
JP2010513277A (ja) * 2006-12-13 2010-04-30 ギリード・サイエンシズ・インコーポレーテッド COPDおよび慢性気管支炎の治療のためのムスカリン受容体アンタゴニストおよびβ−アゴニストの共通プロドラッグとしてのモノホスフェート
ES2554646T3 (es) 2007-02-23 2015-12-22 Theravance Biopharma R&D Ip, Llc Compuestos de difenilmetilo de amonio cuaternario, de utilidad como antagonistas de receptores muscarínicos
DK2197841T3 (da) 2007-09-07 2012-02-06 Theravance Inc Guanidinholdige forbindelser anvendelige som muscariniske receptorantagonister
JP2011506477A (ja) 2007-12-14 2011-03-03 セラヴァンス, インコーポレーテッド ムスカリン受容体拮抗薬として有用なアミジン含有化合物
CA2723981A1 (en) 2008-05-13 2009-11-19 Astrazeneca Ab New compounds 273
US9072734B2 (en) * 2009-04-30 2015-07-07 Teijin Pharma Limited Quaternary ammonium salt compounds
WO2014014698A2 (en) * 2012-07-16 2014-01-23 Barry University Inc. Bitopic muscarinic agonists and antagonists and methods of synthesis and use thereof
EP3111978B1 (de) 2015-07-03 2021-09-01 Novartis AG Zum lesen von in einem datenspeichermittel eines behälters gespeicherten informationen angepasster inhalator
CN115279731A (zh) * 2020-03-11 2022-11-01 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3240784A (en) 1966-03-15 Esters of quaternary z-hydroxy methyl piperidinium compounds
US2746966A (en) 1953-11-02 1956-05-22 Lakeside Lab Inc Esters of bis-(nu-substituted-3-hydroxypiperidinium) alkanes
GB833820A (en) * 1957-10-17 1960-04-27 Beecham Res Lab Improvements in or relating to the preparation of pyrrolidyl esters and quaternary compounds thereof
JPS6018661B2 (ja) * 1976-01-01 1985-05-11 太田製薬株式会社 1−(1,3−ジオキソラン−4−イルメチル)ピペリジノ−ル誘導体
JPS5427570A (en) * 1977-07-30 1979-03-01 Ota Pharma Stereoisomer of 44acyloxyy11 alkyll11*1*33dioxolanee44 ylmethyl* pideridinium salt derivative
JPS5679688A (en) * 1979-12-04 1981-06-30 Ota Seiyaku Kk 4-acyloxy-1- 1,3-dioxoran-2-ylmethyl piperidine derivative and its production
JPS5835177A (ja) * 1981-08-26 1983-03-01 Dainippon Pharmaceut Co Ltd 2−環状アミノ−2−(1,2−ベンズイソキサゾ−ル−3−イル)酢酸エステル類並びにその酸付加塩類および第4級アンモニウム塩類
JPS58208270A (ja) * 1982-05-28 1983-12-03 Dainippon Pharmaceut Co Ltd α−環状アミノフエニル酢酸エステル類並びにその酸付加塩類及び第4級アンモニウム塩類
GB9023023D0 (en) * 1990-10-23 1990-12-05 Barlow Richard B Pharmaceutical compositions
WO1996033973A1 (fr) * 1995-04-28 1996-10-31 Banyu Pharmaceutical Co., Ltd. Derives disubstitues en position 1,4 de piperidine
JP2001504459A (ja) 1996-11-11 2001-04-03 ノエ・クリスティアン・エル 対掌体純粋な、塩基性アリール―シクロアルキル―ヒドロキシカルボン酸エステル、その製造方法及びこれを薬剤に使用する方法
CA2415468A1 (en) * 2000-07-11 2003-01-10 Yoshio Ogino Ester derivatives
ES2206021B1 (es) * 2002-04-16 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de pirrolidinio.
EP1957451B1 (de) * 2005-11-10 2011-10-19 Nicholas S. Bodor Weiche anticholinerge zwitterionen

Also Published As

Publication number Publication date
US7947730B2 (en) 2011-05-24
EP1638940B1 (de) 2010-08-25
BRPI0411738A (pt) 2006-08-08
PT1638940E (pt) 2010-11-08
PE20050231A1 (es) 2005-05-20
MXPA05013823A (es) 2006-02-28
WO2005000815A2 (en) 2005-01-06
TW200526573A (en) 2005-08-16
WO2005000815A3 (en) 2005-04-14
US20060287362A1 (en) 2006-12-21
AR044851A1 (es) 2005-10-05
AU2004251867B2 (en) 2008-08-07
PL1638940T3 (pl) 2011-02-28
EP1638940A2 (de) 2006-03-29
AU2004251867A1 (en) 2005-01-06
CA2526991C (en) 2012-03-27
JP2008529965A (ja) 2008-08-07
ATE478845T1 (de) 2010-09-15
CA2526991A1 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
DE60225274D1 (de) Chinolinderivate als liganden für den neuropeptid-y-rezeptor
DE602004028821D1 (de) Pyrrolidiniumderivative als liganden für den muscarinen m3-rezeptor
DE602004015724D1 (de) Diazepinoindolderivate als kinaseinhibitoren
DE602004029412D1 (de) Fahrerhaus für eine Erdbewegungsmaschine
DE602004024420D1 (de) Chinazolinderivate als antitumormittel
DE60209004D1 (de) Verbindungen verwendbar als zwischenprodukte für 4-aminochinolinderivate
IS8108A (is) Ný efnasambönd
ATE387202T1 (de) Pyrrolidinderivate als histaminrezeptor-liganden
ATE335426T1 (de) Ausziehführungsgarnitur für schubladen
DE602004005498D1 (de) Fluoreffiziente appreturen für textilien
IS8228A (is) Ný asetídínefnasambönd
JP2008525358A5 (ja) M3ムスカリン受容体としてのピロリジニウム誘導体
ATE400206T1 (de) Ausziehführungsgarnitur für schubladen
ATE421506T1 (de) Neue benzimidazolderivate
IS8292A (is) Ný efnasambönd
DE112004002056D2 (de) Hydraulische Schaltung für den Strebausbau
DE602004014772D1 (de) Pyrrol-2,5-dithionderivate als modulatoren des liver-x-rezeptors
DE602004011446D1 (de) Kleiderbügel für Strickware
ATE377008T1 (de) Imidazolderivate als glutamatrezeptorantagonisten
DE602004004295D1 (de) 6-ä(substituiertes)phenylütriazolopyrimidine als antikrebsmittel
DE50301232D1 (de) Skibindung, insbesondere für den langlauf
ATE394372T1 (de) G-lactamderivate als prostaglandinagonisten
DE60324848D1 (de) Ausgleichsmechanismus für drehwelle
ATE433956T1 (de) Cannabinoid-rezeptorliganden
DE502004008685D1 (de) Fadenführervorrichtung für ringspindel

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN